Epithalon is typically administered via subcutaneous injection
Maar, K., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., & Bock-Marquette, I
Archives of Gerontology and Geriatrics, 44 , 213-216
Human results are not established, and large human trials have not been completed, which is a critical limit to keep in mind
Transitioning to Weekly and Monthly Regimens After the first week, the dose is changed to weekly injections for a month
It's involved in cellular energy production and can be beneficial for individuals with fatigue or mitochondrial disorders